A Cross-Sectional Study on Side Effects of “Corbevax” Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh

A Cross-Sectional Study on Side Effects of “Corbevax” Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh

Background: The first mass vaccination program for COVID-19 in India started on January 16, 2021. Initially, Covaxin and Covishield were used. Later, the Government of India has approved the usage of Corbevax, a Hyderabad-based biological E SARS-CoV-2 (COVID-19) vaccine among 12- to 14-year age grou...

Full description

Saved in:
Bibliographic Details
Main Authors: Chhaya Mittal, Harimu Bargayary, Mohit Saini
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Indian Journal of Community Medicine
Subjects:
aefi
aesi
corbevax vaccine
covid-19
pandemic
side effects
vaccination
Online Access:https://journals.lww.com/10.4103/ijcm.ijcm_681_23
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items